HBI Deals+Insights / M&A/IPOs

Dr Lal PathLabs buys in Bangladesh as results show decline in revenue growth

Indian lab diagnostics chain Dr. Lal has acquired a lab-buying company, and says it is planning rapid growth in the country. The group’s Q1 2018 results show that revenue growth nearly halved year-on-year.

We would welcome your thoughts on this story. Email your views to Ariane Jugieux or call 0207 183 3779.